Logo image
Mortality Risk for Operated and Nonoperated Vertebral Fracture Patients in the Medicare Population
Journal article   Peer reviewed

Mortality Risk for Operated and Nonoperated Vertebral Fracture Patients in the Medicare Population

Avram Allan Edidin, Kevin L Ong, Edmund Lau and Steven M Kurtz
Journal of bone and mineral research, v 26(7), pp 1617-1626
09 Feb 2011
PMID: 21308780

Abstract

Biological and medical sciences Fundamental and applied biological sciences. Psychology Skeleton and joints Vertebrates: osteoarticular system, musculoskeletal system Vertebral Compression Fracture Mortality Medicare Kyphoplasty Vertebroplasty
Vertebral compression fractures (VCFs) are associated with increased mortality risk, but the association between surgical treatment and survivorship is unclear. We evaluated the mortality risk for VCF patients undergoing conservative treatment (nonoperated), kyphoplasty, and vertebroplasty. Survival of VCF patients in the 100% U.S. Medicare data set (2005-2008) was estimated by the Kaplan-Meier method, and the differences in mortality rates at up to 4 years were assessed by Cox regression (adjusted for comorbidities) between operated and nonoperated patients and between kyphoplasty and vertebroplasty patients. An instrumental variables analysis was used to evaluate mortality-rate difference between kyphoplasty and vertebroplasty patients. A total of 858,978 VCF patients were identified, including 119,253 kyphoplasty patients and 63,693 vertebroplasty patients. At up to 4 years of follow-up, patients in the operated cohort had a higher adjusted survival rate of 60.8% compared with 50.0% for patients in the nonoperated cohort (p<.001) and were 37% less likely to die [adjusted hazard ratio (HR) = 0.63, p<.0011. The adjusted survival rates for VCF patients following vertebroplasty or kyphoplasty were 57.3% and 62.8%, respectively (p<.001). The relative risk of mortality for kyphoplasty patients was 23% lower than that for vertebroplasty patients (adjusted HR = 0.77, p<.001). Using physician preference as an instrument, the absolute difference in the adjusted survival rate at 3 years was 7.29% higher in patients receiving kyphoplasty than vertebroplasty (p<.001), compared with a crude absolute rate difference of 5.09%. This study established the mortality risk associated with VCFs diagnosed between 2005 and 2008 with respect to different treatment modalities for elderly patients in the entire Medicare population.

Metrics

11 Record Views
185 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
Web of Science research areas
Endocrinology & Metabolism
Logo image